Semaglutide

Compounded semaglutide from a licensed US 503A pharmacy with a real prescription is legitimate.

Short answer: yes, if (and only if) the compounded product contains the same dose of the same molecule with the same purity.

Yes. Compounded semaglutide is still available in 2026 through state-licensed 503A pharmacies prescribing for patient-specific clinical needs.

Compounded semaglutide is legally available through 503A pharmacies in 2026 when prescribed for an individual patient with documented clinical need.

Introduction When properly compounded by a licensed 503A or 503B pharmacy using USP-grade semaglutide active pharmaceutical ingredient, compounded semaglutide contains the same molecule that…

Wegovy is Novo Nordisk’s FDA-approved semaglutide for chronic weight management, approved June 2021 at the 2.4 mg weekly dose.

Ozempic is Novo Nordisk’s brand-name semaglutide injection approved by the FDA in December 2017 for type 2 diabetes.

Switching between Ozempic, Wegovy, and compounded semaglutide is straightforward because the active ingredient is identical.

Compounded semaglutide is a sterile injectable peptide that requires refrigeration between 36°F and 46°F (2°C-8°C).